These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23459105)

  • 1. Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography.
    Recio E; Cifuentes C; Macías J; Mira JA; Parra-Sánchez M; Rivero-Juárez A; Almeida C; Pineda JA; Neukam K
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):905-11. PubMed ID: 23459105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometry.
    Neukam K; Recio E; Camacho A; Macías J; Rivero A; Mira JA; López C; Almeida C; de la Torre J; Pineda JA
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):801-7. PubMed ID: 19773664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection.
    Fernandez-Fuertes M; Macías J; Corma-Gómez A; Rincón P; Merchante N; Gómez-Mateos J; Pineda JA; Real LM
    Sci Rep; 2020 Apr; 10(1):6736. PubMed ID: 32317646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults.
    Price JC; Dodge JL; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski S; Tien PC
    AIDS; 2017 Sep; 31(15):2119-2125. PubMed ID: 28723710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
    de Lédinghen V; Wong GL; Vergniol J; Chan HL; Hiriart JB; Chan AW; Chermak F; Choi PC; Foucher J; Chan CK; Merrouche W; Chim AM; Le Bail B; Wong VW
    J Gastroenterol Hepatol; 2016 Apr; 31(4):848-55. PubMed ID: 26514665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
    Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
    Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients.
    Macías J; Real LM; Rivero-Juárez A; Merchante N; Camacho A; Neukam K; Rivero A; Mancebo M; Pineda JA
    HIV Med; 2016 Nov; 17(10):766-773. PubMed ID: 27028546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study.
    Lupșor-Platon M; Feier D; Stefănescu H; Tamas A; Botan E; Sparchez Z; Maniu A; Badea R
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):35-42. PubMed ID: 25822432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled attenuation parameter for steatosis grading in chronic hepatitis C compared with digital morphometric analysis of liver biopsy: impact of individual elastography measurement quality.
    Mendes LC; Ferreira PA; Miotto N; Zanaga L; Lazarini MS; Gonçales ESL; Pedro MN; Gonçales FL; Stucchi RSB; Vigani AG
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):959-966. PubMed ID: 29727388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection.
    Li Vecchi V; Soresi M; Giannitrapani L; Di Carlo P; Mazzola G; Colletti P; Terranova A; Vizzini G; Montalto G
    Int J Infect Dis; 2012 May; 16(5):e397-402. PubMed ID: 22425495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis.
    Mohr R; Boesecke C; Dold L; Schierwagen R; Schwarze-Zander C; Wasmuth JC; Weisensee I; Rockstroh JK; Trebicka J
    Medicine (Baltimore); 2018 Apr; 97(17):e0462. PubMed ID: 29702998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study.
    Yoo JJ; Yoo YJ; Moon WR; Kim SU; Jeong SW; Park HN; Park MG; Jang JY; Park SY; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kim SG; Kim YS; Kim JH; Yeon JE; Byun KS
    Korean J Intern Med; 2020 Nov; 35(6):1346-1353. PubMed ID: 31694366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication.
    Chromy D; Mandorfer M; Bucsics T; Schwabl P; Bauer D; Scheiner B; Schmidbauer C; Lang GF; Szekeres T; Ferenci P; Trauner M; Reiberger T
    AIDS Patient Care STDS; 2019 May; 33(5):197-206. PubMed ID: 31067123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Sánchez-Conde M; Montes Ramírez ML; Bellón Cano JM; Caminoa A; Alvarez Rodríguez F; González Garcia J; Miralles Martín P; Bernardino de la Serna I; Bernardo de Quirós JC; Arribas López JR; Cosín Ochaíta J; Pascual Pareja JF; Alvarez E; Berenguer JB
    J Viral Hepat; 2011 Jul; 18(7):e278-83. PubMed ID: 21129129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with controlled attenuation parameter (CAP).
    Cardoso AC; Perez RM; de Figueiredo-Mendes C; Carvalho Leite N; Moraes-Coelho HS; Villela-Nogueira CA
    J Viral Hepat; 2018 Nov; 25(11):1244-1250. PubMed ID: 29768686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled attenuation parameter for the detection of hepatic steatosis in patients with chronic hepatitis B.
    Chen J; Wu D; Wang M; Chen E; Bai L; Liu C; Liao J; Tang H
    Infect Dis (Lond); 2016 Sep; 48(9):670-5. PubMed ID: 27241724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter: a cross-sectional study.
    Sulyok M; Makara M; Rupnik Z; Ferenci T; Újhelyi E; Kormos L; Gerlei Z; Szlávik J; Horváth G; Vályi-Nagy I
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):679-85. PubMed ID: 25923943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.